Distinguishing autoimmune pancreatitis from pancreaticobiliary cancers: Current strategy

Annals of Surgery

Volumn 255, Issue 2, 2012, Pages 248-258

  Agrawal, Shefali ^a   Daruwala, Cherag ^b   Khurana, Jasvir ^b  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN G4; IMMUNOMODULATING AGENT; RITUXIMAB;

ASPIRATION BIOPSY; AUTOIMMUNE PANCREATITIS; BILE DUCT CANCER; BILE DUCT CARCINOMA; BILIARY TRACT SCINTISCANNING; CANCER DIAGNOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHOLANGITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LACRIMAL GLAND; LIVER RESECTION; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREAS SCINTISCANNING; PANCREATICODUODENECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; REVIEW; SALIVARY GLAND; SEX DIFFERENCE; STOMACH; TH1 CELL; TH2 CELL; VATER PAPILLA;

AUTOIMMUNE DISEASES; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT NEOPLASMS; CHOLANGIOCARCINOMA; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; HUMANS; PANCREATIC NEOPLASMS; PANCREATITIS;

EID: 84855828510     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182324549     Document Type: Review

References (94)

1. Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688-698.
2. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-1568.
3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344: 732-738. (Pubitemid 32204991)
4. Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol. 2004;99:1605-1616. (Pubitemid 39180112)
5. Nishimori I, Tamakoshi A, Otsuki M; Research Committee on Intractable Diseases of the Pancreas, Ministry of Health, Labour, and Welfare of Japan. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol. 2007;42(Suppl 18):6-8. (Pubitemid 46863930)
6. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-1016. (Pubitemid 44118845)
7. Kamisawa T. IgG4-related sclerosing disease. Intern Med. 2006;45:125-126. (Pubitemid 43349436)
8. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol. 2007;102:2417-2425. (Pubitemid 47631797)
9. Erdogan D, Kloek JJ, ten Kate FJ, et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg. 2008;95:727-734.
10. Corvera CU, Blumgart LH, Darvishian F, et al. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg. 2005;201:862-869. (Pubitemid 41689315)
11. Hamano H, Kawa S, Uehara T, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152-157. (Pubitemid 40922461)
12. Gamblin TC, Krasinskas AM, Slivka AS, et al. Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma. J Gastrointest Surg. 2009;13:713-721.
13. Gerhards MF, Vos P, van Gulik TM, et al. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg. 2001;88: 48-51. (Pubitemid 32066056)
14. Weber SM, Cubukcu-Dimopulo O, Palesty JA, et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg. 2003;7:129-137.
15. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg. 2003;237:853-858.
16. Ota M, Katsuyama Y, Hamano H, et al. Two critical genes (HLA-DRB1 and ABCF1) in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics. 2007;59:45-52. (Pubitemid 46011191)
17. Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118:573-581. (Pubitemid 30140856)
18. Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut. 2005;54:703-709. (Pubitemid 40559259)
19. Taniguchi T, Okazaki K, Okamoto M, et al. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas. 2003;27:26-30. (Pubitemid 36775975)
20. Gardner TB, Chari ST. Autoimmune pancreatitis. Gastroenterol Clin North Am. 2008;37:439-460. (Pubitemid 351680530)
21. Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut. 2009;58:1680-1689.
22. Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118:573-581. (Pubitemid 30140856)
23. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538-1546. (Pubitemid 46918338)
24. Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med. 2006;355:2670-2676. (Pubitemid 44969126)
25. Chari ST, Kloeppel G, Zhang L, et al; Autoimmune Pancreatitis International Cooperative Study Group (APICS). Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39:549-554.
26. Nishimori I, Tamakoshi A, Kawa S, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Research Committee on Intractable Pancreatic Diseases, the Ministry of Health and Welfare of Japan. Pancreas. 2006;32:244-248.
27. Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119-1127. (Pubitemid 36909533)
28. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140-148.
29. Maire F, Le Baleur Y, Rebours V, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011;106:151-156.
30. Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004;233:345-352. (Pubitemid 39423790)
31. Kawamoto S, Siegelman SS, Hruban RH, et al. Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT. Radiographics. 2008;28:157-170.
32. Takahashi N, Fletcher JG, Fidler JL, et al. Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol. 2008;190:280-286. (Pubitemid 351196595)
33. TakahashiN, Fletcher JG, HoughDM,et al. Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. AJR Am J Roentgenol. 2009;193:479-484.
34. Carbognin G, Girardi V, Biasiutti C, et al. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. Radiol Med. 2009;114:1214-1231.
35. Kamisawa T, Tu Y, Egawa N, et al. CanMRCP replace ERCP for the diagnosis of autoimmune pancreatitis? Abdom Imaging. 2009;34:381-384.
36. Ozaki Y, Oguchi K, Hamano H, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol. 2008;43:144-151. (Pubitemid 351344556)
37. Lee TY, Kim MH, Park do H, et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol. 2009;193:343-348.
38. Bodily KD, Takahashi N, Fletcher JG, et al. Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. AJR Am J Roentgenol. 2009;192:431-437.
39. Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197-1205. (Pubitemid 46487210)
40. Nakazawa T, OharaH, SanoH, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937-944. (Pubitemid 39655468)
41. Leise MD, Smyrk TC, Takahashi N, et al. IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis. Dig Dis Sci. 2011;56:1290-1294.
42. Kamisawa T, Tu Y, Nakajima H, et al. Sclerosing cholecystitis associated with autoimmune pancreatitis. World J Gastroenterol. 2006;12:3736-3739. (Pubitemid 43950951)
43. Wang WL, Farris AB, Lauwers GY, et al. Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis. Histopathology. 2009;54:829-836.
44. Takahashi N, Kawashima A, Fletcher JG, et al. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology. 2007;242:791-801.
45. Kamisawa T, Tu Y, Egawa N, et al. Salivary gland involvement in chronic pancreatitis of various etiologies. Am J Gastroenterol. 2003;98:323-326. (Pubitemid 36232380)
46. Kamisawa T, Takuma K, Kuruma S, et al. Lacrimal gland function in autoimmune pancreatitis. Intern Med. 2009;48:939-943.
47. Kamisawa T, Egawa N, Nakajima H, et al. Extrapancreatic lesions in autoimmune pancreatitis. J Clin Gastroenterol. 2005;39:904-907. (Pubitemid 41504673)
48. Tsushima K, Tanabe T, Yamamoto H, et al. Pulmonary involvement of autoimmune pancreatitis. Eur J Clin Invest. 2009;39:714-722.
49. Hirano K, Kawabe T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J. 2006;36:58-61. (Pubitemid 43362549)
50. Sah RP, Chari ST. Clinical hypothyroidism in autoimmune pancreatitis. Pancreas. 2010;39:1114-1116.
51. Ravi K, Chari ST, Vege SS, et al. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis. 2009;15:1326-1330.
52. Shinji A, Sano K, Hamano H, et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc. 2004;59:506-511. (Pubitemid 38437090)
53. Kamisawa T, Anjiki H, Takuma K, et al. Endoscopic approach for diagnosing autoimmune pancreatitis. World J Gastrointest Endosc. 2010;2:20-24.
54. Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 2011;60:666-670.
55. Nishino T, Oyama H, Toki F, et al. Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol. 2010;45:988-996.
56. Farrell JJ, Garber J, Sahani D, et al. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc. 2004;60:927-936. (Pubitemid 39655467)
57. Dietrich CF, Hirche TO, Ott M, et al. Real-time tissue elastography in the diagnosis of autoimmune pancreatitis. Endoscopy. 2009;41:718-720.
58. Unno H, Saegusa H, Fukushima M, et al. Usefulness of endoscopic observation of the main duodenal papilla in the diagnosis of sclerosing pancreatitis. Gastrointest Endosc. 2002;56:880-884. (Pubitemid 36236720)
59. Kamisawa T, Tu Y, Nakajima H, et al. Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining. World J Gastroenterol. 2006;12:2031-2033.
60. Kim MH, Moon SH, Kamisawa T. Major duodenal papilla in autoimmune pancreatitis. Dig Surg. 2010;27:110-114.
61. Kubota K, Kato S, Akiyama T, et al. Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features. Gastrointest Endosc. 2008;68:1204-1208.
62. Moon SH, Kim MH, Park do H, et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest Endosc. 2010;71:960-966.
63. Sugumar A, Chari ST. Diagnosis and treatment of autoimmune pancreatitis. Curr Opin Gastroenterol. 2010;26:513-518.
64. Kaji R, Okabe Y, Ishida Y, et al. Autoimmune pancreatitis presenting with IgG4-positive multiple gastric polyps. Gastrointest Endosc. 2010;71: 420-422.
65. Hirano K, Fukushima N, Tada M, et al. Diagnostic utility of biopsy specimens for autoimmune pancreatitis. J Gastroenterol 2009;44:765-773.
66. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23-28. (Pubitemid 44967946)
67. Levy MJ. Endoscopic ultrasound-guided trucut biopsy of the pancreas: prospects and problems. Pancreatology. 2007;7:163-166. (Pubitemid 47094085)
68. Deshpande V, Mino-Kenudson M, Brugge WR, et al. Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic criteria and pitfalls. Am J Surg Pathol. 2005;29:1464-1471. (Pubitemid 41513296)
69. Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol. 2002;97:1386-1391. (Pubitemid 34664782)
70. Witkiewicz AK, Kennedy EP, Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol. 2008;39:1548-1551.
71. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646-1653. (Pubitemid 47206688)
72. Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol. 2011;23:108-113.
73. Kamisawa T, Imai M, EgawaN, et al. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis. Eur J GastroenterolHepatol. 2008;20:1167-1170.
74. Hosoda H, Okawa-Takatsuji M, Shinmura W, et al. Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody. Pancreas. 2008;37:e1-e7.
75. Gardner TB, Levy MJ, Takahashi N, et al. Misdiagnosis of autoimmune pancreatitis: a caution to clinicians. Am J Gastroenterol. 2009;104:1620-1623.
76. Choi EK, Kim MH, Kim JC, et al. The Japanese diagnostic criteria for autoimmune chronic pancreatitis: is it completely satisfactory? Pancreas. 2006;33: 13-19. (Pubitemid 43995334)
77. Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol. 2006;12:2487-2496.
78. Otsuki M, Chung JB,OkazakiK, Research committee of intractable pancreatic diseases provided by the Ministry of Health, Labour and Welfare of Japan and the Korean Society of Pancreatobiliary Diseases. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403-408.
79. Sugumar A, Chari ST. Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol. 2009;7:S59-S62.
80. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7:1097-1103.
81. Kamisawa T, Imai M,YuiChen P, et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas. 2008;37:e62-e67.
82. Sugumar A, Takahashi N, Chari ST. Distinguishing pancreatic cancer from autoimmune pancreatitis. Curr Gastroenterol Rep. 2010;12:91-97.
83. Cheung MT, Lo IL. IgG4-related sclerosing lymphoplasmacytic pancreatitis and cholangitis mimicking carcinoma of pancreas and Klatskin tumour. ANZ J Surg. 2008;78:252-256.
84. Toomey DP, Swan N, TorreggianiW, et al. Autoimmune pancreatitis: medical and surgical management. JOP. 2007;8:335-343. (Pubitemid 46876794)
85. GhazaleA, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-715. (Pubitemid 351312724)
86. Hadjis NS, Collier NA, Blumgart LH. Malignant masquerade at the hilum of the liver. Br J Surg. 1985;72:659-661. (Pubitemid 15047629)
87. Arikawa S, Uchida M, Kunou Y, et al. Comparison of sclerosing cholangitis with autoimmune pancreatitis and infiltrative extrahepatic cholangiocarcinoma: multidetector-row computed tomography findings. Jpn J Radiol. 2010;28:205-213.
88. Hamano H, Kawa S, Uehara T, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152-157. (Pubitemid 40922461)
89. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504-1507.
90. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56:1719-1724. (Pubitemid 350206299)
91. Maire F, Le Baleur Y, Rebours V, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011;106:151-156.
92. Pannala R, Chari ST. Corticosteroid treatment for autoimmune pancreatitis. Gut. 2009;58:1438-1439.
93. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol. 2007;102:2417-2425. (Pubitemid 47631797)
94. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755-1762.